Inhaler administration

Tiotropium HandiHaler: two inhalations do not mean two capsules

A capsule can contain medicine intended for inhalation rather than swallowing. Spiriva HandiHaler is a useful teach-back case because route, device and the meaning of two inhalations all matter. A patient can repeat the number correctly and still use the wrong amount.

Sources checked October 10, 2026. Independent educational content, not NABP exam questions or individual treatment advice.

Confirm the exact tiotropium product

This lesson concerns Spiriva capsules for the HandiHaler, not every tiotropium presentation. Recover the box and device before giving directions. A brand family or generic active ingredient cannot identify whether the patient has a capsule inhaler or another delivery system.

The label says the capsules are for oral inhalation only and must not be swallowed. "Oral inhalation" means inhaling through the mouth, not taking the capsule orally into the stomach. A patient who stores capsules beside other tablets may need that distinction demonstrated rather than merely repeated in technical language.

Count inhalations and capsules separately

The labeled dose is two inhalations of the powder contents of one 18 mcg capsule once daily. Two inhalations are used to receive the contents of that one capsule. They are not instructions to load two capsules or to take one capsule twice daily.

Ask the patient to show the complete sequence, including which capsule is placed into which device. A verbal answer of "two puffs" can hide a two-capsule error. Use the supplied device instructions for loading, piercing and inhaling; do not transfer an inhalation count from a different inhaler.

Keep maintenance and acute relief separate

The label states that HandiHaler is not a rescue medication and is not intended for acute use. Recover what the patient does during sudden worsening symptoms and whether an acute-care plan exists. Correct maintenance technique does not itself supply an appropriate response to severe breathlessness.

If inhalation triggers paradoxical bronchospasm or an immediate hypersensitivity reaction, the label directs discontinuation and consideration of alternatives. Do not advise repeating the capsule to push through a new respiratory reaction. Acute deterioration needs clinical assessment, not simply stronger adherence encouragement.

Ask about anticholinergic safety concerns

The label contains precautions for worsening narrow-angle glaucoma and urinary retention, and advises close monitoring for anticholinergic effects with moderate to severe renal impairment. Route and device accuracy are only part of the medication review. New eye symptoms or difficulty urinating deserve attention.

Teach-back should be product-specific and followed by checking actual use. This page does not diagnose eye disease, choose a COPD regimen or authorize a formulation switch. It teaches how a correct daily schedule can be undermined by swallowing, capsule-count or rescue-use errors.

A worked case

A patient swallows one Spiriva capsule each morning and loads two additional capsules into the HandiHaler at night because the label says two inhalations. During sudden breathlessness they use another capsule. What must be corrected?

  1. The capsule must not be swallowed.
  2. The two daily inhalations come from one capsule, not two capsules.
  3. HandiHaler is not rescue therapy; recover the acute symptom plan and clinical status.

Answer: Route, unit of administration and maintenance-versus-rescue purpose all differ from the intended instructions.

Try it before reading the answer

Write the key fact, decision and safety check first. These are original practice exercises, not recalled exam items.

1. Do two inhalations mean loading two capsules?

No. They use the contents of one capsule.

2. May the capsule be swallowed if the device is unavailable?

No.

3. Is the correct maintenance dose also an acute rescue instruction?

No. The label says this is not a rescue medicine.

Continue learning

Put the topic into a study plan

Sources and scope

Source dates and limits matter. Follow the current official source for clinical or regulatory decisions. Examples are simplified teaching cases, not prescribing, diagnostic or compounding instructions. Check the full current guidance and individual clinical context.